Stonvex
Discover
  • Dashboard
  • World News
  • Stock News
  • Rankings
  • Surge
  • Quant Picks
  • Screener
Markets
  • Heatmap
  • Gainers & Losers
Tools
  • Compare
  • Calendar
  • Community
HomeRankingsScreenerPortfolioCommunity
Stonvex
Log inGet Started
← Back to search

RMD

Live
Real-time chart · IB-grade AI research · Polygon.io data feed
Set alertSave
  • Overview
  • Financials
  • Filings
  • Short Interest
  • Ownership
  • Ratings
  • Peers
  • Options
  • News
✦
Stonvex AI

RMD

AI Research Report

Powered by Claude

Ready to analyze RMD

Runs the full IB-grade framework: Narrative, Reverse DCF, Comps, Sensitivity, and Deal Radar. Takes 20–40 seconds.

Free preview · 3 reports / hour · No sign-up required

Earnings

Next report date, year-over-year trend, and recent quarter history.

Earnings history activates with Polygon. When configured, this panel shows the next report date, consensus EPS/revenue, and the last 4 quarters of actual-vs-estimate.

Quant Grades

6-factor scoring with sector-relative rank. Updated daily.

Quant grades are available for tickers in our scored universe.

Financial statements

Most recent quarterly filings sourced directly from SEC EDGAR.

Financial statements activate with Polygon. The Developer plan includes quarterly and annual filings sourced directly from SEC EDGAR.

Corporate events

Share this analysis

Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.

Stonvex

AI-powered stock research for US equities.

hello@stonvex.com

Product

  • Rankings
  • Quant Picks
  • Screener
  • Markets
  • Compare
  • Calendar

Company

  • About Stonvex
  • Pricing & Plans
  • Community
  • Help & FAQ
  • Contact Us

Legal

  • Terms of Service
  • Privacy Policy
  • Privacy Consent
  • Disclaimer
  • Notices & Updates

© 2026 Stonvex. All rights reserved.

This site is for informational purposes only. Not investment advice. Past performance does not guarantee future results. Stonvex is not a registered investment advisor (RIA). You must be 18 years or older to use this service.

Latest news

Factor Grades

5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.

📅 Earnings in 15d (Apr 30)

Analyst Consensus

Buy
Based on 25 analysts
Period: 2026-04-01
15 Buy (60%)9 Hold (36%)1 Sell (4%)
Rating Distribution
Strong Buy
4
Buy
11
Hold
9
Sell
0
Strong Sell
1
Trend
2026-04
15/9/1
2026-03
16/8/1
2026-02
16/8/1
2026-01
16/8/1
Resmed Inc

Resmed Inc

Health Care·NEW YORK STOCK EXCHANGE, INC.·US·IPO 1995-06-01
  • ChartMill·16h ago

    ResMed Inc (NYSE:RMD): A Durable Dividend Growth Stock for Passive Income

    ResMed Inc. offers a sustainable dividend with a 10-year growth history, backed by strong profitability, a low payout ratio, and a rock-solid balance sheet for durable passive income.

  • Benzinga·5d ago

    Citigroup Maintains Buy on ResMed, Lowers Price Target to $340

    Citigroup analyst Laura Sutcliffe maintains ResMed (NYSE:RMD) with a Buy and lowers the price target from $345 to $340.

  • View all news →
NEW YORK STOCK EXCHANGE, INC.Market closed
Resmed Inc
Health Care
$230.69
$0.43 (+0.19%)
Open
$228.94
Prev close
$230.26
Day range
$228.39 – $232.32
52W range
$202.00 – $293.81
Mkt cap
$33.61B
P/E
22.6
EPS
$10.12
Beta
0.95

Fundamentals

Valuation
Market Cap
$33.61B
P/E (TTM)
22.61S&P avg ~22
P/S (TTM)
6.22S&P avg ~2.8
P/B
5.56S&P avg ~4.5
P/FCF
18.91S&P avg ~26
EPS (TTM)
$10.12
Book/sh
$43.39
Cash/sh
$9.73
Profitability
Gross Margin
60.85%avg ~45%
Operating Margin
33.70%avg ~15%
Net Margin
27.53%avg ~12%
ROE
24.81%avg ~18%
ROA
18.26%avg ~7%
ROI
22.32%
Payout Ratio
22.25%
FCF/sh
—
Growth & Health
Rev Growth YoY
9.57%
Rev Growth 5Y
11.72%
EPS Growth YoY
19.51%
EPS Growth 5Y
17.38%
Current Ratio
—
Quick Ratio
1.97
Debt/Equity
—
LT Debt/Eq
—
Trading & Dividends
Beta
0.95
52W High
$293.81
52W Low
$202.00
Avg Vol (10D)
915.1K
Avg Vol (3M)
1.03M
Div Yield
1.04%
Div/sh (TTM)
—
Analyst
Buy (25)
Price Performance
5D+1.86%
MTD+2.57%
3M-8.23%
6M-18.17%
YTD-4.40%
1Y+9.36%

Factor Grades

View details →
B-
Overall score: 65/100
C+
Valuation
B
Growth
A
Profitability
D+
Momentum
A-
Financial Health

Recent insider activity

View all →
  • 4PRIMARY DOCUMENT
    6d ago
  • 4PRIMARY DOCUMENT
    12d ago
  • 4PRIMARY DOCUMENT
    13d ago
  • 4PRIMARY DOCUMENT
    Mar 11
  • 4PRIMARY DOCUMENT
    Mar 5